SEARCH

SEARCH BY CITATION

REFERENCES

  • Barker DF, Liu X, Almeida ER. 1996. The BRCA1 and 1A1.3B promoters are parallel elements of a genomic duplication at 17q21. Genomics 38:215222.
  • Brown MA, Jones KA, Nicolai H, Bonjardim M, Black D, McFarlane R, de Jong P, Quirk JP, Lehrach H, Solomon E. 1995. Physical mapping, cloning, and identification of genes within a 500-kb region containing BRCA1. Proc Natl Acad Sci USA 92:43624366.
  • Brown MA, Xu CF, Nicolai H, Griffiths B, Chambers JA, Black D, Solomon E. 1996. The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12:25072513.
  • Catteau A, Harris WH, Xu CF, Solomon E. 1999a. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18:19571965.
  • Catteau A, Xu CF, Brown MA, Hodgson S, Greenman J, Mathew CG, Dunning AM, Solomon E. 1999b. Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions. Br J Cancer 79:759763.
  • Dunning AM, Chiano M, Smith NR, Dearden J, Gore M, Oakes S, Wilson C, Stratton M, Peto J, Easton D, Clayton D, Ponder BA. 1997. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet 6:285289.
  • Easton DF, Bishop DT, Ford D, Crockford GP. 1993. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium. Am J Hum Genet 52:678701.
  • Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA. 1999. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 65:10211029.
  • Greenman J, Mohammed S, Ellis D, Watts S, Scott G, Izatt L, Barnes D, Solomon E, Hodgson S, Mathew C. 1998. Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer. Genes Chromosomes Cancer 21:244249.
  • Martin AM, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL, Nathanson KL. 2001. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J Clin Oncol 19:22472253.
  • Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR. 1999. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943949.
  • Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van’t Veer LJ, Bakker E, van Ommen GJ, Devilee P. 1997. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341345.
  • Puget N, Stoppa-Lyonnet D, Senelonkova ON, Pages S, Lynch HT, Lenoir GM, Mazoyer S. 1999. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59:455461.
  • Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, King MC. 1996. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 6:10291049.
  • Swensen J, Hoffman M, Skolnick MH, Neuhausen SL. 1997. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet 6:15131517.
  • Szabo C, Masiello A, Ryan JF, Brody LC. 2000. The breast cancer information core: database design, structure, and scope. Hum Mutat 16:123131.
  • Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL. 2000. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67:841850.
  • Welcsh PL, King MC. 2001. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10:705713.
  • Xu CF, Brown MA, Nicolai H, Chambers JA, Griffiths BL, Solomon E. 1997a. Isolation and characterization of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum Mol Genet 6:10571062.
  • Xu CF, Chambers JA, Nicolai H, Brown MA, Hujeirat Y, Mohammed S, Hodgson S, Kelsell DP, Spurr NK, Bishop DT, Solomon E. 1997b. Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer 18:102110.